Acquisition of Biocorp by Novo Nordisk, a leading global healthcare company headquartered
2022
Mallya obtains 510(k)!
Mallya obtains 510(k) from the FDA in the USA
2022
Signature of several partnerships
Signature of several partnerships around the Mallya system
2021
Mallya ramp-up
Mallya is commercialized in several countries, including France thanks to the partnership with Roche Diabetes Care. Development for other therapeutic areas
2020
Mallya commercial launch
Distribution agreement signed with Sanofi
2019
Mallya is CE-marked
Medical device class IIb
2018
Onejet wins the Pharmapack Award
BIOCORP rewarded for its connected and motorized auto-injector
